Current Price
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Th...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PProPhase L... | PRPH | $711,970 | — | 0.10 | — | -540.00% | -220.30% | -37.60% |
| 2. | NInotiv Inc | NOTVQ | $390,420 | — | 0.01 | -17.10% | -16.00% | -74.10% | -5.40% |
| 3. | FFresh2 Gro... | FRES | $2.97M | — | 0.17 | — | -699.00% | -216.20% | -69.90% |
| 4. | NENDRA Life | NDRA | $6.61M | — | 1.05 | — | — | -152.00% | — |
| 5. | CCheck-Cap... | CHEK | $9.42M | — | 0.25 | — | — | -226.20% | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Sep 24 | Dec 24 | Mar 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0.02 | 0 | 0 | 0.13 | 0 |
COGS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | -0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
Gross Profit % | - | - | - | -9.32% | - | - | - | - |
| 0.01 | 0.53 | 0.02 | 0.52 | 0.4 | 0.02 | 4.96 | 0.18 | |
EBIT | -0.55 | -0.53 | -0.79 | -0.02 | -0.4 | -0.02 | -4.83 | 0.86 |
OPM % | - | - | - | -101.76% | - | - | -3783.93% | 21195.62% |
Non-Operating Income | 0.29 | -0.38 | -0.59 | 0 | 7.4 | 0 | -7.69 | -0.41 |
PBT | -0.27 | -0.91 | -1.38 | -0.01 | 7 | -0.02 | -12.52 | 0.45 |
Income Tax | 0 | 0 | 0 | 0 | 0.14 | 0 | 0 | -0 |
Tax Rate % | - | - | - | - | 2.06% | - | - | -0.01% |
Net Income | -0.27 | -0.91 | -1.38 | -0.01 | 6.86 | -0.02 | 0.69 | -0.43 |
NPM % | - | - | - | -75.15% | - | - | 544.51% | -10650.71% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Dec 2026 |
|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0.13 |
COGS | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 |
Gross Profit | -0 | -0 | -0.01 | -0.01 | -0.01 | 0 |
Gross Profit % | - | - | - | - | - | - |
| 1.84 | 2.37 | 3.07 | 2.54 | 0.08 | 6.36 | |
EBIT | -1.84 | -2.37 | -3.07 | -2.54 | -0.09 | -6.26 |
OPM % | - | - | - | - | - | -4905.53% |
Non-Operating Income | -0 | -1.65 | -0.66 | -0.24 | 0 | -0 |
PBT | -1.84 | -4.03 | -3.73 | -2.78 | -0.1 | -6.26 |
Income Tax | 0 | 0 | 0 | 0 | 0 | -12.94 |
Tax Rate % | - | - | - | - | - | 206.62% |
Net Income | -1.84 | -4.03 | -3.73 | -2.78 | -0.1 | 6.68 |
NPM % | - | - | - | - | - | 5231.3% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Dec 2026 |
|---|---|---|---|---|---|---|
| 0.07 | 4.78 | 2.62 | 2.61 | 2,903.91 | 0.39 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0.85 | 0.22 | 0.16 | 0.44 | 3,128.66 | 13.36 | |
| 0.09 | 1.71 | 1.81 | 1.41 | 479.77 | 0 | |
Total Assets | 1.01 | 6.71 | 4.6 | 4.46 | 6,512.34 | 13.75 |
| 0.01 | 0.1 | 0.02 | 0.02 | 21.64 | 0 | |
| 0.96 | 3.39 | 1.29 | 1.64 | 3,455.92 | 12.28 | |
| 0.01 | 0.48 | 0.24 | 0.13 | 1.26 | 0 | |
| 0.02 | 2.75 | 3.05 | 2.67 | 2,888.01 | 1.47 | |
| 0 | 0 | 0 | 0 | 145.51 | 0 | |
Total Liabilities | 1.01 | 6.71 | 4.6 | 4.46 | 6,512.34 | 13.75 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Dec 2026 |
|---|---|---|---|---|---|---|
| -0.47 | -0.74 | -2.96 | -2.13 | -0.18 | -0.96 | |
| -0.03 | -1.08 | -0.26 | -0.07 | -0 | -2.51 | |
| 0.7 | 6.1 | 0.46 | 1.87 | 0.18 | 1.97 | |
Net CFNet Cash Flow | 0.2 | 4.27 | -2.77 | -0.33 | 0 | -1.5 |
FCFFree Cash Flow | -0.5 | -2.05 | -3.18 | -2.2 | -0.18 | -0.96 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Dec 2026 |
|---|---|---|---|---|---|---|
| - | -180.3% | -155.6% | -187.4% | -0.0% | 0.4% | |
| 0.01 | 0.14 | 0.19 | 0.08 | 0.00 | - | |
| 32.22 | 1.67 | 0.85 | 1.12 | 2.09 | 9.33 | |
| - | 0.00 | 0.00 | 0.00 | - | 0.00 | |
Cash Conversion | 0.26 | 0.18 | 0.79 | 0.76 | 1.79 | -0.14 |
Payout Ratio | - | - | - | - | - | - |
| - | - | - | - | - | - | |
| -0.09 | -0.20 | -0.19 | -0.14 | -0.01 | 0.33 | |
| - | - | - | - | -66.31 | - | |
| 3.00 | 3.00 | 3.00 | 5.00 | 3.00 | 5.00 | |
| - | - | - | - | - | - | |
| 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 | |
| - | - | - | - | - | 52.3% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns Advanced Biomed Inc, from SEC filings
Schedule 13D / 13G filers (5%+), plus stakes Advanced Biomed Inc holds in others · open a holder to see each filing
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Individual | F5 | 123,840 | 7.50% | SC 13G · 22 Sep 2026 | |
| Individual | F4 | 0 | 0.00% | SC 13G/A · 20 Aug 2026 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Month | Insiders | Shares sold | Value sold | Shares bought | Value bought | Awards, tax, gifts |
|---|---|---|---|---|---|---|
| 1 | — | — | — | — | 176,225 |
Form 4, filed within two business days of each trade. Sales and purchases are open-market; awards, tax withholding, gifts and option exercises are grouped. Amended filings are left out so a restated trade isn't counted twice.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 11,238 | +15.3% | 1.00 | |
| 15 Oct 2026 | 9,747 | -48.4% | 1.00 | |
| 30 Sep 2026 | 18,897 | +91.9% | 1.00 | |
| 15 Sep 2026 | 9,845 | -39.8% | 1.00 | |
| 31 Aug 2026 | 16,357 | -56.2% | 1.00 | |
| 14 Aug 2026 | 37,364 | -34.7% | 1.00 | |
| 31 Jul 2026 | 57,213 | +441.2% | 1.00 | |
| 15 Jul 2026 | 10,571 | -31.3% | 1.00 | |
| 30 Jun 2026 | 15,397 | +73.5% | 1.05 | |
| 15 Jun 2026 | 8,876 | +356.3% | 1.00 | |
| 29 May 2026 | 1,945 | -47.7% | 1.00 | |
| 15 May 2026 | 3,722 | -72.3% | 1.00 | |
| 30 Apr 2026 | 13,424 | -72.7% | 1.00 | |
| 15 Apr 2026 | 49,188 | +87.8% | 1.00 | |
| 31 Mar 2026 | 26,190 | +104.1% | 1.00 | |
| 13 Mar 2026 | 12,832 | -43.5% | 1.00 | |
| 27 Feb 2026 | 22,721 | -68.7% | 1.00 | |
| 13 Feb 2026 | 72,493 | -18.2% | 2.64 | |
| 30 Jan 2026 | 88,631 | -63.3% | 1.69 | |
| 15 Jan 2026 | 241,679 | -33.7% | 7.70 | |
| 31 Dec 2025 | 364,417 | -45.0% | 3.65 | |
| 15 Dec 2025 | 662,889 | +268.2% | 1.00 | |
| 28 Nov 2025 | 180,045 | -47.5% | 1.00 | |
| 14 Nov 2025 | 342,702 | -70.4% | 1.24 |
FINRA consolidated short interest, reported twice a month for every US listing.
Advanced Biomed Inc's SEC filings and earnings call transcripts
What recent news says about Advanced Biomed Inc, scored for sentiment.